TENAX THERAPEUTICS, INC. Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)
TENAX THERAPEUTICS, INC. (TENX) reported Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) of $48.10 thousand for the 8-month period ending 2015-12-31, per its 10-KT filed 2016-03-14.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2016-03-14
- TENAX THERAPEUTICS, INC. fair value, asset, recurring basis, still held, unrealized gain (loss) for fiscal 2015 was $382.43K.
| Period end | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 8 month | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month |
|---|---|---|
| 2015-12-31 | $48.10K 10-KT · filed 2016-03-14 | |
| 2015-04-30 | $382.43K 10-K · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |